Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Healthcare, IT open new road to India-RI friendship

  • Aastha Saboo

Jakarta   /   Thu, August 15 2019   /  01:05 am

Indonesia’s US$5 billion pharmaceutical market is dominated by 178 domestic companies, four state-owned and 24 multinational players, and one of the biggest challenges facing health care in the country today is getting access to medicines at lower prices.In the past few years, the Indonesian government has relaxed norms to create more flexibility in healthcare rules, paving the way for many foreign companies, including from India, to enter the country’s pharmaceutical market.The registration process for medicines marketed in Indonesia has become smoother, and Indonesia today provides greater flexibility for foreign players to invest in the active pharmaceutical ingredient (API) sector and is also looking at allowing 100 percent foreign direct investment (FDI) for foreign firms to set up formulation plants in the country with local partners.Indian pharma companies can capitalize on th...